KA/EN
Register
Medicines reference
Search
Search
Active substance

Taurine

Favourites

Amino sulfonic acid. Registered in Georgia: 1 veterinary product and 1 human medicine. Forms: drops (oral), eye drops.

Dose and use

Doses

We have no dose with a cited source for this substance yet.

Before use

Safety information

No sourced safety entry is currently shown. This does not mean the substance is risk-free.

Latin name
Taurine
Georgian name
ტაურინი
Authorisation status
Authorised veterinary medicine
An authorised veterinary medicine containing this substance exists. Whether a particular use is on-label depends on the species and the indication - see each dose rule.
Registered in Georgia
2 of 2 forms
Products
Bestoxol, Diamond Eyes
Human medicines in Georgia
Bestoxol, Taufon
Human medicines with this substance in the Georgian register of medicines (Ministry of Health), checked on 18 Oct 2026. They are human medicines, not veterinary products; strengths and forms differ.
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
All forms and registration2

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

Bestoxol 40 mg/ml (4%), Eye drops

eye drops, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Potential topical adjunctive use of exact Bestoxol taurine 4% eye drops for canine cataract, corneal injury/dystrophy, retinal disease or glaucoma
Not rateable
No numerical score assigned
vetman assessment

Bestoxol

40 mg/ml (4%), eye drops, human medicine
Assessed clinical scopeDog · Potential topical adjunctive use of exact Bestoxol taurine 4% eye drops for canine cataract, corneal injury/dystrophy, retinal disease or glaucoma · Into the eye
Care settingVeterinarian-directed use only after a complete diagnosis and only if a defensible patient-specific rationale exists without delaying established medical or surgical care
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Yes, human · № რ-033806 · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical product score cannot responsibly be assigned. Exact Bestoxol has a verifiable human formulation and Georgian registration, but no exact-product canine dose, ocular PK, target-animal safety or clinical outcome study was found. The only located canine topical study used a multi-ingredient antioxidant containing taurine plus N-acetyl carnosine, glutathione, cysteine ascorbate and riboflavin in an unmasked preliminary design, so neither its effect nor regimen can be attributed or transferred to Bestoxol.

Taurine biology is real, but it does not create a product-specific veterinary claim. Bestoxol should remain an identity-documented, no-dose, not-rateable human ophthalmic product until direct dog/cat efficacy and safety evidence supports a defined clinical scope.

Important safety and use flags

  • No exact-product dog/cat efficacy, ocular PK, target-animal safety or dose study was found. Do not convert the human label or mechanistic taurine literature into a veterinary product score.
  • Feline taurine deficiency is a nutritional/systemic disorder. Diagnose diet and systemic status and correct dietary taurine; topical Bestoxol is not proven to deliver therapeutic retinal taurine or reverse established degeneration.
  • The preliminary canine cataract study tested a multi-ingredient antioxidant formulation, not Bestoxol or taurine alone. Its unmasked, nonplacebo design and combined actives cannot establish this product’s efficacy or regimen.
  • Do not copy the human two-drop, multi-month cataract/corneal-trauma or glaucoma schedule. No diagnosis-independent dog/cat frequency or course is published here.
  • Do not delay established diagnosis or treatment of cataract, corneal injury, retinal disease, glaucoma, uveitis or infection. Progressive pain, redness, opacity, discharge, pressure change or vision loss requires prompt ophthalmic reassessment.
  • The exact solution contains methyl parahydroxybenzoate. Stop and reassess for irritation, lid swelling, erythema, pruritus or another hypersensitivity reaction; target-animal repeated-dose tolerance is unknown.
  • Avoid dropper-tip contact with the eye, lashes, skin or fingers, recap promptly and do not share a bottle between patients. Follow the exact pack’s storage and post-opening instructions.
  • Safety in pregnant, lactating, breeding or juvenile dogs and cats is not established. Use only after an explicit veterinary benefit-risk decision, and do not infer safety from taurine being a normal nutrient.
  • Current Georgian human registration does not imply veterinary authorisation or efficacy. The controlled EU/GB/US exact-brand negative findings describe market status only and are not used as proof that the product is ineffective.
Assessment sources
  1. Bestoxol exact-product audit2026
  2. Bestoxol Uzbekistan register2026
  3. Bestoxol state-register identity2022
  4. Bestoxol human instruction2016
  5. Merck ophthalmic steroids2026
  6. Canine multi-ingredient cataract study2006
  7. Veterinary non-antibiotic ocular review2026
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Potential topical adjunctive use of exact Bestoxol taurine 4% eye drops for feline cataract, corneal injury/dystrophy, retinal disease or glaucoma
Not rateable
No numerical score assigned
vetman assessment

Bestoxol

40 mg/ml (4%), eye drops, human medicine
Assessed clinical scopeCat · Potential topical adjunctive use of exact Bestoxol taurine 4% eye drops for feline cataract, corneal injury/dystrophy, retinal disease or glaucoma · Into the eye
Care settingVeterinarian-directed use only after a complete diagnosis and only if a defensible patient-specific rationale exists without delaying established medical or surgical care
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Yes, human · № რ-033806 · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical product score cannot responsibly be assigned. Exact Bestoxol has a verifiable human formulation and Georgian registration, but no exact-product feline dose, ocular PK, target-animal safety or clinical outcome study was found. Dietary taurine is essential in cats and deficiency causes retinal degeneration, but that evidence concerns nutrition/systemic status, not topical 4% drops; it cannot establish Bestoxol efficacy, retinal delivery or reversal of established damage.

Taurine biology is real, but it does not create a product-specific veterinary claim. Bestoxol should remain an identity-documented, no-dose, not-rateable human ophthalmic product until direct dog/cat efficacy and safety evidence supports a defined clinical scope.

Important safety and use flags

  • No exact-product dog/cat efficacy, ocular PK, target-animal safety or dose study was found. Do not convert the human label or mechanistic taurine literature into a veterinary product score.
  • Feline taurine deficiency is a nutritional/systemic disorder. Diagnose diet and systemic status and correct dietary taurine; topical Bestoxol is not proven to deliver therapeutic retinal taurine or reverse established degeneration.
  • The preliminary canine cataract study tested a multi-ingredient antioxidant formulation, not Bestoxol or taurine alone. Its unmasked, nonplacebo design and combined actives cannot establish this product’s efficacy or regimen.
  • Do not copy the human two-drop, multi-month cataract/corneal-trauma or glaucoma schedule. No diagnosis-independent dog/cat frequency or course is published here.
  • Do not delay established diagnosis or treatment of cataract, corneal injury, retinal disease, glaucoma, uveitis or infection. Progressive pain, redness, opacity, discharge, pressure change or vision loss requires prompt ophthalmic reassessment.
  • The exact solution contains methyl parahydroxybenzoate. Stop and reassess for irritation, lid swelling, erythema, pruritus or another hypersensitivity reaction; target-animal repeated-dose tolerance is unknown.
  • Avoid dropper-tip contact with the eye, lashes, skin or fingers, recap promptly and do not share a bottle between patients. Follow the exact pack’s storage and post-opening instructions.
  • Safety in pregnant, lactating, breeding or juvenile dogs and cats is not established. Use only after an explicit veterinary benefit-risk decision, and do not infer safety from taurine being a normal nutrient.
  • Current Georgian human registration does not imply veterinary authorisation or efficacy. The controlled EU/GB/US exact-brand negative findings describe market status only and are not used as proof that the product is ineffective.
Assessment sources
  1. Bestoxol exact-product audit2026
  2. Bestoxol Uzbekistan register2026
  3. Bestoxol state-register identity2022
  4. Bestoxol human instruction2016
  5. Merck ophthalmic steroids2026
  6. Feline dietary taurine requirement1978
  7. Feline taurine-deficiency retina1976
  8. Feline taurine nutritional review1982
  9. Veterinary non-antibiotic ocular review2026
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Taurine40 mg/ml
Formulation Type
Eye drops
Administration route
Into the eye
Manufacturer
World Medicine · Türkiye
Registration
Georgia Yes, human
In force until 17 Nov 2026
Human (Ministry of Health, RAMA)
№ რ-033806
Verified on: 22 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified No dog/cat dose or veterinary indication is established for this exact product. Do not copy the human multi-month cataract, corneal-trauma or glaucoma schedules. Feline dietary taurine deficiency requires nutritional/systemic management and is not an indication for these topical drops.

Diamond Eyes, Drops (oral)

eye drops 0.15/20/1 mg/ml, 10 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop (up to 10 kg) or 2 drops (over 10 kg) 1-3 times daily
4.8/10
Weak evidence support
vetman assessment

Diamond Eyes

eye drops 0.15/20/1 mg/ml, 10 ml for dogs and cats
Assessed clinical scopeDog · Full dog label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop (up to 10 kg) or 2 drops (over 10 kg) 1-3 times daily · Into the eye
Care settingOwner eye care after veterinary examination, for mild cases without corneal damage
vetman score 4.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000643 · Verified on 21 Oct 2026

A weak product: a mild antiseptic eye-cleansing drop with no proven treatment effect. Suitable for wiping away discharge, not for treating eye disease.

Regulatory and scientific credibility3.5/10

The exact product is registered in Georgia (000643, valid to 2029) with a current AVZ instruction; it has no international authorisation or independent study, and taurine and succinic acid have no evidence as eye treatments.

Clinical efficacy3.0/10

Dilute chlorhexidine (0.015%) gives some antiseptic cleansing, but no study shows that the product treats conjunctivitis, and true bacterial conjunctivitis needs an ophthalmic antibiotic.

Safety and tolerability6.5/10

The chlorhexidine concentration is low and the label sets maximum courses with breaks; chlorhexidine can irritate a damaged cornea, so ulcers should be excluded first.

Clinical practicality7.0/10

Simple drops with a clear dose and course schedule are easy for owners to use.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Examine and stain the eye first; persistent discharge, squinting or a red eye needs diagnosis, not cleansing drops.
  • Respect the maximum courses: 45 days once daily, 20 days twice daily or 14 days three times daily, each followed by a break.
  • Leave at least 5 minutes between this product and other eye medicines.
  • Taurine and succinic acid have no proven eye benefit; do not rely on this product for infection.
  • Use in pregnancy and in newborns needs veterinary benefit-risk assessment.
Assessment sources
  1. AVZ Diamond Eyes2026
  2. Georgia NFA register 20262026
  3. Merck ophthalmic antimicrobials2025
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop 1-3 times daily
4.8/10
Weak evidence support
vetman assessment

Diamond Eyes

eye drops 0.15/20/1 mg/ml, 10 ml for dogs and cats
Assessed clinical scopeCat · Full cat label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop 1-3 times daily · Into the eye
Care settingOwner eye care after veterinary examination, for mild cases without corneal damage or active herpesvirus disease
vetman score 4.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000643 · Verified on 21 Oct 2026

A weak product for cats: a mild antiseptic eye-cleansing drop with no proven treatment effect. Feline conjunctivitis needs a diagnosis and specific therapy.

Regulatory and scientific credibility3.5/10

The exact product is registered in Georgia (000643, valid to 2029) with a current AVZ instruction; it has no international authorisation or independent study, and taurine and succinic acid have no evidence as eye treatments.

Clinical efficacy3.0/10

Dilute chlorhexidine gives some antiseptic cleansing, but no study shows that the product treats feline conjunctivitis, which is mostly viral or chlamydial and needs specific treatment.

Safety and tolerability6.5/10

The chlorhexidine concentration is low and the label sets maximum courses with breaks; chlorhexidine can irritate a damaged cornea, so ulcers should be excluded first.

Clinical practicality7.0/10

Simple single drops with a clear course schedule are easy for owners to use.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Examine and stain the eye first; squinting, a red eye or herpetic ulcers need diagnosis and specific treatment, not cleansing drops.
  • Respect the maximum courses: 45 days once daily, 20 days twice daily or 14 days three times daily, each followed by a break.
  • Leave at least 5 minutes between this product and other eye medicines.
  • It does not treat feline herpesvirus or Chlamydia felis.
  • Use in pregnancy and in newborn kittens needs veterinary benefit-risk assessment.
Assessment sources
  1. AVZ Diamond Eyes2026
  2. Georgia NFA register 20262026
  3. ABCD 20262026
  4. ABCD Chlamydia felis guideline2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Chlorhexidine0.15 mg/ml Taurine20 mg/ml Succinic acid1 mg/ml
Formulation Type
Drops (oral)
Administration route
Into the eye
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1138, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 01 May 2029
Veterinary (National Food Agency)
In the register: თვალის წვეთები ბრილიანტის თვალები
№ 000643
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗